These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 38281945)
1. m Li Y; Lou S; Zhang J; Zhao S; Lou G J Transl Med; 2024 Jan; 22(1):113. PubMed ID: 38281945 [TBL] [Abstract][Full Text] [Related]
2. lncRNA-MEG3 Suppresses the Proliferation and Invasion of Melanoma by Regulating CYLD Expression Mediated by Sponging miR-499-5p. Long J; Pi X Biomed Res Int; 2018; 2018():2086564. PubMed ID: 29808164 [TBL] [Abstract][Full Text] [Related]
3. lncRNA MEG3 modified epithelial-mesenchymal transition of ovarian cancer cells by sponging miR-219a-5p and regulating EGFR. Wang L; Yu M; Zhao S J Cell Biochem; 2019 Oct; 120(10):17709-17722. PubMed ID: 31161607 [TBL] [Abstract][Full Text] [Related]
4. Niraparib restrains prostate cancer cell proliferation and metastasis and tumor growth in mice by regulating the lncRNA MEG3/miR-181-5p/GATA6 pathway. Cheng J; Sun Y; Zhao H; Ren W; Gao D; Wang Z; Lv W; Dong Q PeerJ; 2023; 11():e16314. PubMed ID: 38047026 [TBL] [Abstract][Full Text] [Related]
5. LncRNA MEG3 inhibits the progression of prostate cancer by modulating miR-9-5p/QKI-5 axis. Wu M; Huang Y; Chen T; Wang W; Yang S; Ye Z; Xi X J Cell Mol Med; 2019 Jan; 23(1):29-38. PubMed ID: 30565858 [TBL] [Abstract][Full Text] [Related]
6. Downregulation of long noncoding RNA TUSC7 promoted cell growth, invasion and migration through sponging with miR-616-5p/GSK3β pathway in ovarian cancer. Zhu LM; Li N Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7253-7265. PubMed ID: 32706063 [TBL] [Abstract][Full Text] [Related]
7. lncRNA MEG3 inhibits pituitary tumor development by participating in cell proliferation, apoptosis and EMT processes. Wang X; Li X; Wang Z Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649837 [TBL] [Abstract][Full Text] [Related]
8. HNRNPA2B1-mediated m Li K; Gong Q; Xiang XD; Guo G; Liu J; Zhao L; Li J; Chen N; Li H; Zhang LJ; Zhou CY; Wang ZY; Zhuang L J Transl Med; 2023 Jun; 21(1):382. PubMed ID: 37308993 [TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA matrilineal expression gene 3 inhibits hepatocellular carcinoma progression by targeting microRNA-5195-3p and regulating the expression of forkhead box O1. Li M; Liao H; Wu J; Chen B; Pang R; Huang J; Zhu Y Bioengineered; 2021 Dec; 12(2):12880-12890. PubMed ID: 34895065 [TBL] [Abstract][Full Text] [Related]
10. LncRNA MEG3 negatively modified osteosarcoma development through regulation of miR-361-5p and FoxM1. Shen B; Zhou N; Hu T; Zhao W; Wu D; Wang S J Cell Physiol; 2019 Aug; 234(8):13464-13480. PubMed ID: 30624782 [TBL] [Abstract][Full Text] [Related]
11. The ceRNA Mechanism of lncRNA MEG3/miR-21-5p/SPRY2 in Cell Proliferation and Apoptosis in Bladder Cancer. Hong Y; Li Z; Su Y; Pu H; Zhang X Crit Rev Eukaryot Gene Expr; 2024; 34(1):55-68. PubMed ID: 37824392 [TBL] [Abstract][Full Text] [Related]
12. The lncRNA MEG3/miR-16-5p/VGLL4 regulatory axis is involved in etoposide-induced senescence of tumor cells. Tao Y; Yue P; Miao Y; Gao S; Wang B; Leng SX; Meng X; Zhang H J Gene Med; 2021 Feb; 23(2):e3291. PubMed ID: 33141998 [TBL] [Abstract][Full Text] [Related]
13. LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer. Hao T; Huang S; Han F Cell Biochem Funct; 2020 Dec; 38(8):1089-1099. PubMed ID: 32638404 [TBL] [Abstract][Full Text] [Related]
14. lncRNA MIAT Regulates Cell Growth, Migration, and Invasion Through Sponging miR-150-5p in Ovarian Cancer. Zhou S; Xu A; Song T; Gao F; Sun H; Kong X Cancer Biother Radiopharm; 2020 Nov; 35(9):650-660. PubMed ID: 32186927 [No Abstract] [Full Text] [Related]
15. Upregulation of the lncRNA Meg3 induces autophagy to inhibit tumorigenesis and progression of epithelial ovarian carcinoma by regulating activity of ATG3. Xiu YL; Sun KX; Chen X; Chen S; Zhao Y; Guo QG; Zong ZH Oncotarget; 2017 May; 8(19):31714-31725. PubMed ID: 28423647 [TBL] [Abstract][Full Text] [Related]
16. Tumor-suppressive MEG3 induces microRNA-493-5p expression to reduce arabinocytosine chemoresistance of acute myeloid leukemia cells by downregulating the METTL3/MYC axis. Wang A; Chen Y; Shi L; Li M; Li L; Wang S; Wang C J Transl Med; 2022 Jun; 20(1):288. PubMed ID: 35761379 [TBL] [Abstract][Full Text] [Related]
17. LncRNA MEG3 inhibits cell proliferation and induces apoptosis in laryngeal cancer via miR-23a/APAF-1 axis. Zhang X; Wu N; Wang J; Li Z J Cell Mol Med; 2019 Oct; 23(10):6708-6719. PubMed ID: 31328388 [TBL] [Abstract][Full Text] [Related]
18. RNA methylation-mediated LINC01559 suppresses colorectal cancer progression by regulating the miR-106b-5p/PTEN axis. Shi K; Yang S; Chen C; Shao B; Guo Y; Wu X; Zhao L; Yang X; Zhang Q; Yuan W; Sun Z Int J Biol Sci; 2022; 18(7):3048-3065. PubMed ID: 35541914 [TBL] [Abstract][Full Text] [Related]
19. METTL3 Promotes the Growth and Invasion of Melanoma Cells by Regulating the lncRNA SNHG3/miR-330-5p Axis. Chu S; Li Y; Wu B; Rong G; Hou Q; Zhou Q; Du D; Li Y Cell Transplant; 2023; 32():9636897231188300. PubMed ID: 37606168 [TBL] [Abstract][Full Text] [Related]
20. lncRNA MEG3 inhibits the growth of hepatocellular carcinoma cells by sponging miR-9-5p to upregulate SOX11. Liu Z; Chen JY; Zhong Y; Xie L; Li JS Braz J Med Biol Res; 2019; 52(10):e8631. PubMed ID: 31531526 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]